8-K

UNITED STATESSECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934


July 17, 2008
Date of Report (Date of earliest event reported)


AptarGroup, Inc.
(Exact name of registrant as specified in its charter)

Delaware	1-11846	36-3853103
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

475 West Terra Cotta Avenue, Suite E, Crystal Lake, Illinois 60014

(Address of principal executive offices)

Registrant’s telephone number, including area code: 815-477-0424

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02     Results of Operations and Financial Condition.

On July 17, 2008, AptarGroup, Inc. (“AptarGroup”) announced its results of operations and financial condition for the quarter and six months ended June 30, 2008.  The press release regarding this announcement is furnished as Exhibit 99.1 hereto.

The information in Item 2.02 of this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Item 9.01     Financial Statements and Exhibits.

(d) Exhibits

99.1    Press release issued by AptarGroup, Inc. dated July 17, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			AptarGroup, Inc.
Date:	July 17, 2008	By:	/s/ Stephen J. Hagge
			Stephen J. Hagge
			Executive Vice President, Chief Operating Officer, and Chief Financial Officer

EXHIBIT INDEX

99.1 Press Release issued by AptarGroup, Inc. dated July 17, 2008.

EX-99.1

Exhibit 99.1

AptarGroup Reports Record Second Quarter Results;
Raises Dividend and Increases Shares Authorized for Repurchase

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--July 17, 2008--AptarGroup, Inc. (NYSE:ATR) today reported record second quarter results. The Company’s Board of Directors also increased the quarterly dividend by 15% and authorized the repurchase of an additional 4 million shares of common stock.

Second Quarter 2008 Highlights

• Earnings per share increased 23% to a record $.64 per share
• Sales rose 17% to a record $551.3 million
• Pharma segment achieved record results
• $20.3 million spent to repurchase 460,000 shares

SECOND QUARTER RESULTS

For the quarter ended June 30, 2008, sales increased 17% to a record $551.3 million from $472.9 million a year ago. Dispensing system sales accounted for 6% of the growth while changes in exchange rates contributed 11%. Contributions from acquisitions were not significant in the quarter.

Commenting on the quarter, Peter Pfeiffer, President and CEO, said, “I’m pleased to report another record quarter. We benefited from changes in currency exchange rates and the broad diversification of our business. The quarter started strongly but we saw some softness toward the end of the quarter particularly in the personal care, fragrance/cosmetic and household markets. This softness was offset by increased demand from the pharmaceutical and food/beverage markets.”

Second Quarter Segment Sales Analysis (Growth Over Prior Year)
	Beauty & Home		Closures		Pharma		Total AptarGroup
Product and Custom Tooling Sales	4	%	10	%	4	%	6	%
Currency Effects	11	%	9	%	13	%	11	%
Total Growth	15	%	19	%	17	%	17	%

Pfeiffer commented, “Operating income increased to a record $65.2 million, up 13% from $57.5 million a year ago primarily due to the strong performance of the Pharma segment. Pharma segment income grew 33% to $35.0 million on strong demand for all product categories. Beauty & Home segment income rose to $26.8 million or an increase of 2% while Closures segment income declined 4% to $12.8 million. Our Beauty & Home and Closures segments were affected by slowing sales toward the end of the quarter and margins were negatively affected by the continual rise in raw material and transport costs particularly in the U.S. We are increasing our prices as market conditions permit in order to mitigate this cost inflation but there is a normal delay in this process.”

Diluted earnings per share increased 23% due primarily to operating performance, higher interest income, lower effective tax rate, and foreign currency effects, to a record $.64 per share compared to $.52 per share in the prior year.

YEAR-TO-DATE RESULTS

Pfeiffer stated, “We have completed a record first half of the year in what many considered a difficult economic environment, especially in the U.S. We also finished the first six months well ahead of our exceptional 2007 results.”

For the year-to-date, sales increased 17% to a record $1.1 billion from $922.7 million a year ago. Dispensing system sales increased 7% while changes in exchange rates added 10%. Operating income increased to a record $120.0 million, up 15% from $104.1 million a year ago. Diluted earnings per share increased 25% to $1.16 per share compared to $.93 per share a year ago.

OUTLOOK

Pfeiffer added, “As we look at the third quarter, we expect challenging economic conditions in the U.S. and Europe, particularly in light of continuing rising input costs. Increased demand from the pharmaceutical and food/beverage markets, and the developing regions of the world, is expected to contribute to our growth over the prior year. Last year we reported third quarter diluted earnings per share of $.56 per share that included a positive impact of $.03 per share related to a reduction in net deferred tax liabilities stemming from a change in the German tax law. Excluding this deferred tax adjustment, diluted earnings per share in the third quarter of last year were $.53 per share. At this time, we anticipate that diluted earnings per share for the third quarter of this year will be in the range of $.55 to $.58 per share.”

CASH DIVIDEND INCREASE AND SHARE REPURCHASE PROGRAM

The Board of Directors increased the quarterly dividend by 15% to $.15 per share, payable August 20, 2008 to shareholders of record as of July 30, 2008. The increase brings the annual dividend rate to $.60 per share up from $.52 per share.

During the quarter, the Company repurchased approximately 460,000 shares of common stock for approximately $20.3 million leaving approximately 1.1 million shares authorized for repurchase at the end of the second quarter. The Board today approved the repurchase of an additional 4 million shares.

Pfeiffer commented, “We continue to generate strong cash flow and our financial position allows us to return value to shareholders with increased dividends and additional share repurchases. While we are in terrific position to take advantage of strategic opportunities as they present themselves, our strong balance sheet also allows the Board to take these actions that improve shareholder value.”

OPEN CONFERENCE CALL

There will be a conference call on Friday, July 18, 2008 at 8:00 a.m. CDT to discuss the Company’s second quarter results for 2008. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investor Relations page at www.aptargroup.com. Replay of the conference call can also be accessed on the Investor Relations page of the web site.

AptarGroup, Inc. is a leading global supplier of a broad range of innovative dispensing systems for the fragrance/cosmetic, personal care, pharmaceutical, household and food/beverage markets. AptarGroup is headquartered in Crystal Lake, Illinois, with manufacturing facilities in North America, Europe, Asia, and South America. For more information, visit the AptarGroup web site at www.aptargroup.com.

This press release contains forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on management’s beliefs as well as assumptions made by and information currently available to management. Accordingly, AptarGroup’s actual results may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist including, but not limited to, those related to overall business conditions in the various markets in which AptarGroup operates, the competitive marketplace, fiscal and monetary policy, changes in foreign exchange rates, direct or indirect consequences of acts of war or terrorism, labor relations and other risks and uncertainties discussed from time to time in AptarGroup’s filings with the Securities and Exchange Commission, including its Form 10-K’s and 10-Q’s. Readers are cautioned not to place undue reliance on forward-looking statements.

APTARGROUP, INC.
Condensed Consolidated Financial Statements (Unaudited)
(In Thousands, Except Per Share Data)
CONSOLIDATED STATEMENTS OF INCOME
	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2008		2007		2008		2007
Net Sales	$ 551,319		$ 472,876		$ 1,083,577		$ 922,717
Cost of Sales (exclusive of depreciation shown below)	372,908		318,595		735,688		618,855
Selling, Research & Development and Administrative	78,819		65,805		160,643		139,530
Depreciation and Other Amortization	34,372		30,944		67,327		60,181
Operating Income (1)	65,220		57,532		119,919		104,151
Other Income/(Expense):
Interest Expense	(4,336	)	(4,612	)	(8,943	)	(9,455	)
Interest Income	3,410		1,756		6,859		3,378
Equity in Results of Affiliates	126		111		223		268
Minority Interests	(3	)	1		19		18
Miscellaneous, net	259		(820	)	(685	)	(1,210	)
Income before Income Taxes	64,676		53,968		117,392		97,150
Provision for Income Taxes	19,403		17,000		35,218		30,602
Net Income	$ 45,273		$ 36,968		$ 82,174		$ 66,548
Net Income per Share - Basic	$ 0.67		$ 0.54		$ 1.21		$ 0.96
Net Income per Share - Diluted	$ 0.64		$ 0.52		$ 1.16		$ 0.93
Average Number of Shares – Basic	68,038		69,037		68,103		69,113
Average Number of Shares - Diluted	70,477		71,443		70,937		71,886

(1) - Included in total Operating Income are expenses related to stock options of approximately $1.4 million and $8.6 million in the second quarter and first six months, respectively, of 2008, and $2.1 million and $10.8 million in the second quarter and first six months, respectively, of 2007.

APTARGROUP, INC.
Condensed Consolidated Financial Statements (Unaudited)
(continued)
(In Thousands)
CONSOLIDATED BALANCE SHEETS
	June 30, 2008	December 31, 2007
ASSETS
Cash and Equivalents	$ 296,629	$ 313,739
Receivables, net	435,056	360,736
Inventories	298,861	272,556
Other Current Assets	64,907	56,414
Total Current Assets	1,095,453	1,003,445
Net Property, Plant and Equipment	729,782	656,508
Goodwill, net	239,283	222,668
Other Assets	29,768	29,329
Total Assets	$ 2,094,286	$ 1,911,950
LIABILITIES AND STOCKHOLDERS' EQUITY
Short-Term Obligations	$ 245,644	$ 216,159
Accounts Payable and Accrued Liabilities	374,265	349,030
Total Current Liabilities	619,909	565,189
Long-Term Obligations	125,167	146,711
Deferred Liabilities	87,106	81,032
Total Liabilities	832,182	792,932
Stockholders' Equity	1,262,104	1,119,018
Total Liabilities and Stockholders' Equity	$ 2,094,286	$ 1,911,950

APTARGROUP, INC.
Condensed Consolidated Financial Statements (Unaudited)
(continued)
(In Thousands)
SEGMENT INFORMATION
	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2008		2007		2008		2007
NET SALES
Beauty & Home	$ 288,911		$ 250,186		$ 572,674		$ 492,144
Closures	144,245		121,532		278,521		241,513
Pharma	118,162		101,157		232,377		189,058
Other	1		1		5		2
Total Net Sales	$ 551,319		$ 472,876		$ 1,083,577		$ 922,717
SEGMENT INCOME (1)
Beauty & Home	$ 26,843		$ 26,443		$ 56,203		$ 52,575
Closures	12,831		13,363		24,053		27,344
Pharma	34,951		26,356		64,867		49,038
Corporate Expenses and Other	(9,023	)	(9,338	)	(25,647	)	(25,730	)
Total Income Before Interest and Taxes	$ 65,602		$ 56,824		$ 119,476		$ 103,227
Less: Interest Expense, Net	926		2,856		2,084		6,077
Income before Income Taxes	$ 64,676		$ 53,968		$ 117,392		$ 97,150
SEGMENT INCOME %
Beauty & Home	9.3	%	10.6	%	9.8	%	10.7	%
Closures	8.9	%	11.0	%	8.6	%	11.3	%
Pharma	29.6	%	26.1	%	27.9	%	25.9	%
Income before Interest and Taxes	11.9	%	12.0	%	11.0	%	11.2	%

Notes to Condensed Consolidated Financial Statements:

(1) - The Company evaluates performance of its business units and allocates resources based upon income before interest expense net of interest income, stock option and corporate expenses, income taxes and unusual items.

CONTACT:
AptarGroup, Inc.
Stephen J. Hagge, 815-477-0424